Literature DB >> 16194107

Screening method for the discovery of potential cancer chemoprevention agents based on mass spectrometric detection of alkylated Keap1.

Guowen Liu1, Aimee L Eggler, Birgit M Dietz, Andrew D Mesecar, Judy L Bolton, John M Pezzuto, Richard B van Breemen.   

Abstract

Natural products are important sources of drugs such as cancer chemopreventive agents, but most assays for the discovery of compounds in natural product extracts are low throughput and provide little information about lead compounds in these complex mixtures. The induction of enzymes such as quinone reductase, glucuronyl transferases, glutathione S-transferases, and sulfotransferases can protect cells against the toxic and neoplastic effects of carcinogens. An increase in the concentration of Nrf2 in the nucleus of a cell upregulates the antioxidant response element and induces the expression of these chemopreventive enzymes. Based on the hypothesis that ubiquitination and proteosome-mediated degradation of Nrf2 in the cytoplasm decreases upon the covalent modification of 1 or more of the 27 cysteine sulfhydryl groups on Keap1 (a protein that sequesters Nrf2 in the cytoplasm) and results in higher Nrf2 levels both in the cytoplasm and in the nucleus, a high-throughput mass spectrometry-based screening assay was designed to detect alkylation of sulfhydryl groups of human Keap1. As an initial high-throughput screening step, matrix-assisted laser desorption time-of-flight mass spectrometry was used to determine whether incubation of Keap1 with a botanical sample produced adducts of Keap1. Test extracts found to form adducts with Keap1 were then incubated with the alternative biological nucleophile glutathione and characterized using LC-UV-MS-MS. After validation of the assay using two model alkylating agents, fractions of an extract of hops (Humulus lupulus L.) from the brewing industry were screened, and several compounds were detected as potential chemopreventive agents. Two of these electrophilic hops constituents were identified as xanthohumol and xanthohumol D. In a subsequent cell-based assay, xanthohumol and xanthohumol D were confirmed to be potent inducers of quinone reductase, and reaction with Keap1 was also confirmed. Therefore, this new mass spectrometric screening assay was demonstrated to facilitate the discovery of chemoprevention agents in complex natural product mixtures.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16194107     DOI: 10.1021/ac050892r

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  16 in total

1.  Screening for natural chemoprevention agents that modify human Keap1.

Authors:  Chenqi Hu; Dejan Nikolic; Aimee L Eggler; Andrew D Mesecar; Richard B van Breemen
Journal:  Anal Biochem       Date:  2011-10-22       Impact factor: 3.365

Review 2.  The role of chalcones in suppression of NF-κB-mediated inflammation and cancer.

Authors:  Vivek R Yadav; Sahdeo Prasad; Bokyung Sung; Bharat B Aggarwal
Journal:  Int Immunopharmacol       Date:  2010-12-22       Impact factor: 4.932

Review 3.  Biological reactive intermediates (BRIs) formed from botanical dietary supplements.

Authors:  Birgit M Dietz; Judy L Bolton
Journal:  Chem Biol Interact       Date:  2010-10-21       Impact factor: 5.192

4.  Angelica sinensis and its alkylphthalides induce the detoxification enzyme NAD(P)H: quinone oxidoreductase 1 by alkylating Keap1.

Authors:  Birgit M Dietz; Dongting Liu; Ghenet K Hagos; Ping Yao; Andreas Schinkovitz; Samuel M Pro; Shixin Deng; Norman R Farnsworth; Guido F Pauli; Richard B van Breemen; Judy L Bolton
Journal:  Chem Res Toxicol       Date:  2008-09-23       Impact factor: 3.739

5.  Biological and chemical standardization of a hop (Humulus lupulus) botanical dietary supplement.

Authors:  Elizabeth Krause; Yang Yuan; Atieh Hajirahimkhan; Huali Dong; Birgit M Dietz; Dejan Nikolic; Guido F Pauli; Judy L Bolton; Richard B van Breemen
Journal:  Biomed Chromatogr       Date:  2014-06       Impact factor: 1.902

6.  Screening natural products for inhibitors of quinone reductase-2 using ultrafiltration LC-MS.

Authors:  Yongsoo Choi; Katherine Jermihov; Sang-Jip Nam; Megan Sturdy; Katherine Maloney; Xi Qiu; Lucas R Chadwick; Matthew Main; Shao-Nong Chen; Andrew D Mesecar; Norman R Farnsworth; Guido F Pauli; William Fenical; John M Pezzuto; Richard B van Breemen; Richard R van Breemen
Journal:  Anal Chem       Date:  2010-12-30       Impact factor: 6.986

Review 7.  Botanicals and Their Bioactive Phytochemicals for Women's Health.

Authors:  Birgit M Dietz; Atieh Hajirahimkhan; Tareisha L Dunlap; Judy L Bolton
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

8.  EST analysis of hop glandular trichomes identifies an O-methyltransferase that catalyzes the biosynthesis of xanthohumol.

Authors:  Jana Nagel; Lana K Culley; Yuping Lu; Enwu Liu; Paul D Matthews; Jan F Stevens; Jonathan E Page
Journal:  Plant Cell       Date:  2008-01-25       Impact factor: 11.277

9.  Differential regulation of detoxification enzymes in hepatic and mammary tissue by hops (Humulus lupulus) in vitro and in vivo.

Authors:  Birgit M Dietz; Ghenet K Hagos; Jillian N Eskra; Gihani T Wijewickrama; Jeffrey R Anderson; Dejan Nikolic; Jian Guo; Brian Wright; Shao-Nong Chen; Guido F Pauli; Richard B van Breemen; Judy L Bolton
Journal:  Mol Nutr Food Res       Date:  2013-03-20       Impact factor: 5.914

10.  The University of Illinois at Chicago/National Institutes of Health Center for Botanical Dietary Supplements Research for Women's Health: from plant to clinical use.

Authors:  Norman R Farnsworth; Elizabeth C Krause; Judy L Bolton; Guido F Pauli; Richard B van Breemen; James G Graham
Journal:  Am J Clin Nutr       Date:  2008-02       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.